FindTrial
Sign In

A STUDY TO COMPARE SINGLE VERSUS DOUBLE LEVEL ULTRASOUND GUIDED THORACIC PARAVERTEBRAL BLOCK FOR POSTOPERATIVE PAIN IN BREAST CANCER SURGERY.

SINGLE LEVEL VERSUS DOUBLE LEVEL ULTRASOUND GUIDED THORACIC PARAVERTEBRAL BLOCK FOR POSTOPERATIVE ANALGESIA IN TOTAL MASTECTOMY WITH AXILLARY CLEARANCE. A RANDOMIZED CONTROLLED TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/06/004701
Enrollment
56
Registered
2014-06-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- ASA 1 OR ASA II PHYSICAL STATUS CARCINOMA BREASTPATIENTS POSTED FOR TMAC SURGERY

Interventions

Intervention1: double level ultrasound guided thoracic paravertebral block at T2 and T5 level: inj.ropivacaine 0.5% at dose of 0.3 ml per kg and half of total dose at each level Control Intervention1:

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 60 ASA I/II female patients in the age group of 18-60 years, scheduled to undergo total mastectomy with axillary clearance surgery under general anaesthesia

Exclusion criteria

Exclusion criteria: Local infection at the block site, coagulopathy, extreme obesity, allergy to local anaesthetics, decreased pulmonary reserve, cardiac disorders, renal dysfunction, pre-existing neurological deficits, psychiatric illness and wide spread metastatic disease.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of this study will be 24 hour analgesic consumption.Timepoint: first 24 hours—

Secondary

MeasureTime frame
It include pain scores, time to first request for rescue analgesic and side-effects in the postoperative period.Timepoint: first 24 hours—

Countries

India

Contacts

Public ContactRAJESH KASIMAHANTI

PGIMER CHANDIGARH

drsumanarora@hotmail.com09855134441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026